Cramer: Buying Trea...
Health Care: Drugs
Enzon Pharmaceuticals Inc. (ENZN: NASDAQ)
$6.41 -0.02 | -0.31%
06/01/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 48.07M | 97.86M | 184.62M | 196.94M |
| Cost of Sales | -5.90M | -8.40M | 29.36M | 42.25M |
| Gross Operating Profit | 53.98M | 106.27M | 155.27M | 154.69M |
| Selling, General, and Administrative Expenses | 17.40M | 27.40M | 63.94M | 71.31M |
| Research & Development | 41.11M | 57.02M | 70.23M | 58.09M |
| Operating Income before D & A (EBITDA) | -4.53M | 21.85M | 21.11M | 25.29M |
| Depreciation & Amortization | 5.90M | 8.40M | 18.93M | 20.12M |
| Interest Income | 1.74M | 0.00 | 0.00 | 0.00 |
| Other Income - Net | 91.00K | 3.75M | 9.32M | 7.22M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -14.63M | 3.18M | 9.89M | 10.27M |
| Interest Expense | 5.93M | 6.32M | 11.51M | 12.68M |
| Pre-Tax Income | -20.56M | -3.14M | -1.63M | -2.41M |
| Income Taxes | 205.00K | -337.00K | -2.31M | 304.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -20.76M | -2.80M | 683.00K | -2.72M |
| Net Income From Discontinued Operations | 0.00 | 180.04M | 0.00 | 0.00 |
| Net Income From Total Operations | -20.76M | 177.24M | 683.00K | -2.72M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -20.76M | 177.24M | 683.00K | -2.72M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-14.74M | 11.23M | 2.29M | -598.00K |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -20.76M | -2.80M | 683.00K | -2.72M |
| Basic EPS from Continuing Ops. | -0.40 | -0.05 | 0.02 | -0.06 |
| Basic EPS from Discontinued Ops. | 0.00 | 3.08 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.40 | 3.03 | 0.02 | -0.06 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.40 | 3.03 | 0.02 | -0.06 |
| Basic Normalized Net Income/Share | -0.28 | 0.20 | 0.07 | -0.01 |
| EPS fr Continuing Ops. | -0.40 | -0.05 | 0.01 | -0.06 |
| EPS fr Discontinued Ops | 0.00 | 3.08 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.40 | 3.03 | 0.01 | -0.06 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.40 | 3.03 | 0.01 | -0.06 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.28 | 0.20 | 0.03 | -0.01 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ENZN
- Portfolio NameUser Type
- ProSeth Klarman - Baupost Group
- ProCarl Icahn
- UserGFNN Stockdiagnostics 12
- UserVermonty #1
- ProRichard Perry - Perry Capital
- ProMichael Price - MFP Investors
- UserInternational Value Fund
- UserRichard_stocks
- ContributorBarron's Activist Stocks 5-...
- UserASCO 2010 Part 2
Latest ENZN Headlines from TheStreet
- Enzon Pharmaceuticals Inc. (ENZN): Today's Featured Drugs Loser 10.05.11 | 04:10 pm
- Enzon Stock Hits New 52-Week Low (ENZN) 09.30.11 | 03:09 pm
- Enzon Stock Hits New 52-Week Low (ENZN) 09.22.11 | 02:09 pm
- Enzon Pharmaceuticals Inc. Stock Downgraded (ENZN) 08.09.11 | 07:08 am
- Enzon Stock Hits New 52-Week Low (ENZN) 08.04.11 | 11:08 am
- Enzon Stock Hits New 52-Week Low (ENZN) 07.27.11 | 10:07 am
- Enzon Stock Hits New 52-Week Low (ENZN) 06.17.11 | 04:06 pm
- 2 New Stock Picks From Baupost's Klarman 05.16.11 | 06:05 am
- Carl Icahn Bets Big on 23 Stocks 02.16.11 | 06:02 am
- Enzon Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript 05.10.10 | 11:05 pm
Press Releases for ENZN
- Enzon Announces Reduction In Force To Align Operations With Research And Development Activities - Business Wire 09.22.11 | 04:09 pm
- ENZON Names Ana I. Stancic Chief Financial Officer - Business Wire 05.31.11 | 06:05 am
- Enzon Announces Discontinuation Of PEG-SN38 Program In Metastatic Colorectal Carcinoma In Light Of Evolving Standards Of Care - Business Wire 05.19.11 | 06:05 am
- Enzon Reports 1st Quarter 2011 Results - Business Wire 05.06.11 | 08:05 am
- Enzon Presents Data At 2011 AACR Meeting - Business Wire 04.05.11 | 04:04 pm
- Enzon Appoints Richard Mulligan, Ph.D. Vice-Chairman Of The Board; Adopts Majority Vote Standard For Election Of Directors - Business Wire 03.17.11 | 04:03 pm
- Enzon Reports 2010 Results - Business Wire 02.17.11 | 04:02 pm
- Enzon To Release Fourth Quarter 2010 Earnings On Thursday, February 17, 2011; Conference Call And Webcast To Follow - Business Wire 02.10.11 | 07:02 am
- Enzon To Begin Phase 1 Study Of Novel Androgen Receptor MRNA Antagonist In Castration-Resistant Prostate Cancer - Business Wire 01.10.11 | 07:01 am
- Enzon Board Authorizes Share Repurchase Program - Business Wire 12.21.10 | 04:12 pm
Partner Headlines for ENZN
- 5 Biotech Stocks That Could Double - Seeking Alpha 02.01.12 | 07:02 am
- Billionaire Carl Icahn's Top Stock Picks And Portfolio Activity - Seeking Alpha 11.23.11 | 08:11 am
- Tracking Seth Klarman's Baupost Group Holdings - Seeking Alpha 10.18.11 | 09:10 am
- 11 Stocks Carl Icahn And Jim Simons Are Bullish On - Seeking Alpha 09.18.11 | 09:09 am
- 10 Profitable, Small Cap Stocks With Strong Growth And Bullish Trends - Seeking Alpha 08.22.11 | 08:08 am
- Weak Top Line Widens Enzon Loss - Analyst Blog - Zacks 08.09.11 | 10:08 am
- Weak Top Line Widens Enzon Loss - Analyst Blog - Zacks 08.09.11 | 10:08 am
- Seth Klarman's Favorite Stock Picks - Seeking Alpha 07.26.11 | 09:07 am
- Enzon Pharmaceuticals (ENZN) - Bear of the Day - Zacks 06.15.11 | 01:06 am
- Enzon Pharmaceuticals (ENZN) - Bear of the Day - Zacks 06.07.11 | 01:06 am
